Clinical Trial Update: A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating single-dose DSM265 or OZ439 for antimalarial activity and transmission-blocking in healthy subjects with induced malaria infection; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• DSM265
• OZ439

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-06-05